Prognostic indices and therapy in IgA nephropathy: toward a solution
1Department of Nephrology and (Internal) Medicine, Manchester Royal Infirmary, Manchester, UK. francis.ballardie@cmmc.nhs.uk
Abstract:
IgA nephropathy is the primary renal disease with the greatest impact on services. The paucity of trials with high evidence-based standards gives emphasis to issues of the rationalization of therapies. Now that certain treatments are increasingly accepted and others under evaluation, reliable discriminatory tests are essential to define and select patients at high risk of progression before irreversible loss of renal tissue, while avoiding drug exposure in others.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Nephrotic Syndrome III : Nursing Management
Nephrotic Syndrome II : Assessment and Medical Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury III: Clinical Manifestations

